Global Companion Diagnostics (CDx) Development Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

The Companion Diagnostics (CDx) Development Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Companion Diagnostics (CDx) Development Services market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Infectious Diseases accounting for  % of the Companion Diagnostics (CDx) Development Services global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Feasibility Studies segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Companion Diagnostics (CDx) Development Services include Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, and Qﾲ Solutions, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Companion Diagnostics (CDx) Development Services market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Feasibility Studies
    Assay Development
    Analytical Validation
    Clinical Validation
    Others
Market segment by Application, can be divided into
    Infectious Diseases
    Neurological Disorders
Market segment by players, this report covers
    Geneuity-Clinical Research Services
    Interpace Biosciences
    Labcorp
    Quest Diagnostics
    Qﾲ Solutions
    ResearchDx
    Almac Diagnostic Services
    Biocartis
    Cerba Research
    Eurofins Scientific
    MLM Medical Labs
    Qiagen
    BGI Genomics
    MEDx Translational Medicine
    Medical Biological Laboratories (MBL)
    Novogene
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Companion Diagnostics (CDx) Development Services product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Companion Diagnostics (CDx) Development Services, with revenue, gross margin and global market share of Companion Diagnostics (CDx) Development Services from 2019 to 2022.
Chapter 3, the Companion Diagnostics (CDx) Development Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Companion Diagnostics (CDx) Development Services market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Companion Diagnostics (CDx) Development Services research findings and conclusion, appendix and data source.